AF
PCSA icon

Allworth Financial’s Processa Pharmaceuticals PCSA Stock Holding History

Allworth Financial’s Portfolio PCSA Stock Details PCSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3
Closed -$117 – 4021
2024
Q3 		$117 Hold
3
– – ﹤0.01% 3652
2024
Q2 		$139 Hold
3
– – ﹤0.01% 3587
2024
Q1 		$202 Hold
3
– – ﹤0.01% 3447
2023
Q4 		$569 Hold
3
– – ﹤0.01% 3103
2023
Q3 		$426 Hold
3
– – ﹤0.01% 3081
2023
Q2 		$846 Hold
3
– – ﹤0.01% 2783
2023
Q1 		$851 Hold
3
– – ﹤0.01% 2729
2022
Q4 		$1.87K Hold
3
– – ﹤0.01% 2265
2022
Q3 		$4K Hold
3
– – ﹤0.01% 1955
2022
Q2 		$5K Hold
3
– – ﹤0.01% 1761
2022
Q1 		$5K Hold
3
– – ﹤0.01% 1639
2021
Q4 		$8K Hold
3
– – ﹤0.01% 1472
2021
Q3 		$15K Hold
3
– – ﹤0.01% 1125
2021
Q2 		$14K Buy
+3
New +$11.6K ﹤0.01% 948

Other funds holding PCSA

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MMA
Miracle Mile Advisors Los Angeles, California $8.53B AUM 21.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Allworth Financial's PCSA Position: Q4 2024 in Review

Allworth Financial sold out of Processa Pharmaceuticals (PCSA) in Q4 2024, closing a stake of 3 shares — an estimated $117 sold.

Allworth Financial first reported a position in PCSA in Q2 2021 and held it in 14 quarters. The position peaked at $15K in Q3 2021. 8 funds tracked by Wall St. Rank hold PCSA as of Q4 2024.

  • Allworth Financial reported no remaining Processa Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Allworth Financial sold 3 Processa Pharmaceuticals shares in Q4 2024, an estimated $117.
  • Allworth Financial first reported a position in Processa Pharmaceuticals in Q2 2021 and held it in 14 quarters.
  • Allworth Financial's Processa Pharmaceuticals position peaked at $15K in Q3 2021.
  • 8 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q4 2024.

Based on Allworth Financial's 13F filing for Q4 2024, filed 30 Jan 2025.